TABLE 3.

Number of clinically important isolates in 714 urine samples in study B

SpeciesNo. of isolatesNo. of clinically important isolates detected with:
DipStreak device with US3 mediumUS3 medium platesCLED medium
TotalPure≥105 CFU/ml<105 CFU/mlTotalPure≥105 CFU/ml<105 CFU/mlTotalPure≥105 CFU/ml<105 CFU/ml
Candida spp.1515101231510123149122
Citrobacter spp.15151115015111501511150
Escherichia coli420419361401184203603992141536539916
Enterobacter spp.12128120128120128120
Enterococcus spp.136132701171513570118171367011818
Klebsiella spp.70705966470576377057664
Ochrobactrum anthropi1111011101110
PMP groupa65655061465496146548614
Pseudomonas spp.43432742143274124327412
Serratia marcescens3323032303230
Staphylococcus aureus7767076707670
Staphylococcus spp.8848084808480
Streptococcus agalactiae15151415015141501514150
Total810805623b76045809619c75554804622d75846
  • a PMP group, Proteus-Morganella-Providencia group.

  • b Five cultures yielded a double bacterial isolation on US3 and CLED medium plates, but only one strain was identified on DipStreak US3 medium.

  • c One cultures yielded a double bacterial isolation on DipStreak US3 and CLED media, but only one strain was identified on US3 medium plates.

  • d Five urine samples with a double bacterial isolation contained two E. coli variants, but only one strain was identified on CLED medium.